Johnson & Johnson -- Physician Payments Report

Spending Summary

Johnson & Johnson has made $5,280,356.01 in total payments to 0 physicians across 777 recorded transactions.

• Total Physician Spending: $5,280,356.01
• Total Physicians Paid: 0
• Total Payment Transactions: 777
• Spending Aggressiveness Score: 50/100 -- This score reflects the overall spending intensity relative to industry peers. A higher score indicates more aggressive physician payment patterns.

AI Spending Analysis

The following analysis was generated by artificial intelligence based on Johnson & Johnson's payment history, specialty targeting patterns, and industry comparisons. This analysis is not medical or legal advice.

Johnson & Johnson (J&J), a global healthcare giant, demonstrates a significant but focused approach to physician engagement through its reported payments. With a total physician payment volume of $162,699.99 across 18 transactions, J&J's spending in this dataset appears moderate compared to some of the largest pharmaceutical spenders, suggesting a targeted strategy rather than broad-based outreach. The company's primary focus areas are Ophthalmology, General Surgery, Dermatology, and Internal Medicine. This concentration is logical given J&J's extensive portfolio, which includes significant offerings in vision care (e.g., Acuvue contact lenses, surgical ophthalmology devices), surgical equipment and biomaterials, dermatological treatments, and a wide array of pharmaceuticals and medical devices relevant to internal medicine. The substantial payment to Ophthalmology ($88,800.42 across 4 payments) highlights a key area of investment, likely related to product development, clinical trials, or educational initiatives for advanced eye care procedures and products. General Surgery ($34,294.09 across 6 payments) and Dermatology ($20,972.68 across 3 payments) also represent considerable financial engagement, aligning with J&J's presence in surgical technologies and skin health solutions. Internal Medicine ($18,632.80 across 5 payments) captures a broader range of potential physician interactions, reflecting the diverse therapeutic areas J&J addresses. The data does not provide a breakdown of payment types (e.g., consulting, speaking, research, meals), which would offer deeper insight into the nature of these relationships. Geographic focus is not explicitly detailed in the provided data, but J&J's global presence implies widespread engagement. Comparing J&J's spending to industry peers requires access to a broader dataset of pharmaceutical payments; however, its focused specialty targeting suggests a strategic allocation of resources. For patients, understanding these relationships is crucial. Payments to physicians, while often for legitimate purposes like research, education, and consulting, can potentially influence prescribing habits or treatment recommendations. Transparency in these payments allows patients to have informed discussions with their doctors about potential conflicts of interest and to ensure that treatment decisions are based solely on clinical evidence and individual patient needs. Patients should feel empowered to ask their physicians about any financial relationships they have with pharmaceutical companies and how these relationships might inform their care.

Medical Specialties Targeted by Johnson & Johnson

The following medical specialties receive the most payments from Johnson & Johnson. Understanding which specialties a company targets can provide insight into their product portfolio and marketing strategy.

Top Physicians Paid by Johnson & Johnson

The following physicians have received the largest payments from Johnson & Johnson. Click on a physician's name to view their complete payment report.

Recent Payment Records

The following table shows the most recent payments from Johnson & Johnson to physicians as recorded in the CMS Open Payments database.

Frequently Asked Questions About Johnson & Johnson

How much does Johnson & Johnson spend on doctors?

Johnson & Johnson reported a total of $162,699.99 in physician payments across 18 recorded transactions. This figure represents payments made to doctors for various potential reasons, such as consulting, speaking engagements, research, or other services. While this amount provides a snapshot, it's important to note that J&J's overall spending across all physicians and all payment types may be broader and is subject to reporting requirements.

Which doctors receive the most from Johnson & Johnson?

Based on the provided recent payments, Dr. John Anderson received the largest single payment of $71,984.52 for Ophthalmology. Other significant recipients include Dr. Charles Baker ($15,735.99 in Ophthalmology), Dr. Heather Mitchell ($15,451.48 in Internal Medicine), Dr. Stephanie King ($13,931.24 in General Surgery), and Dr. Andrew Young ($14,090.29 in General Surgery). These payments are for specific services or collaborations.

What specialties does Johnson & Johnson target?

Johnson & Johnson's reported payments are concentrated in specific medical specialties that align with its product lines. The top targeted specialties are Ophthalmology ($88,800.42 across 4 payments), General Surgery ($34,294.09 across 6 payments), Dermatology ($20,972.68 across 3 payments), and Internal Medicine ($18,632.80 across 5 payments). This focus reflects J&J's significant presence in vision care, surgical devices, dermatological treatments, and a broad range of pharmaceuticals relevant to internal medicine.

Is Johnson & Johnson spending more or less than average?

The provided data shows Johnson & Johnson's total physician payments at $162,699.99 across 18 transactions. To determine if this is more or less than average, a comparative analysis with a broader dataset of pharmaceutical company spending would be necessary. However, the focused nature of J&J's spending on specific specialties suggests a strategic allocation rather than a widespread, high-volume payment strategy across all medical fields.

Should I be concerned if my doctor takes money from Johnson & Johnson?

It's understandable to be curious about your doctor's financial relationships. Payments from companies like Johnson & Johnson can be for legitimate purposes such as research, education, or consulting that benefits medical advancement. However, transparency is key. Patients should feel comfortable asking their doctor about any financial ties to pharmaceutical companies and how these relationships, if any, inform their treatment recommendations. The decision to prescribe or recommend a treatment should always prioritize the patient's best interest and be based on clinical evidence.

What types of payments does Johnson & Johnson make?

The provided data details the total amount and number of payments, as well as the specialties and specific doctors involved. However, it does not break down the specific types of payments made (e.g., consulting fees, speaking fees, research grants, meals, travel, or royalties). Understanding the nature of these payments would offer greater insight into the purpose of J&J's financial engagement with physicians.

Does Johnson & Johnson have a history of marketing violations?

Information regarding a company's history of marketing violations is typically available through regulatory bodies like the U.S. Food and Drug Administration (FDA) or the U.S. Department of Justice. While this specific dataset focuses on physician payments, a comprehensive understanding of J&J's compliance history would require consulting public records from these agencies and other relevant sources that track regulatory actions and settlements.

Understanding Pharmaceutical Company Payment Reports

Under the Physician Payments Sunshine Act, pharmaceutical and medical device companies must report all payments and transfers of value to licensed physicians and teaching hospitals. Johnson & Johnson is required to disclose every payment, including consulting fees, speaking engagements, meals, travel, research funding, and ownership interests.

A high spending total does not necessarily indicate improper behavior. Large pharmaceutical companies with extensive product portfolios naturally make more payments to physicians. However, examining the patterns of spending -- which specialties are targeted, which doctors receive the most, and what types of payments predominate -- can provide valuable insights for patients.

Related Resources

• Search for other pharmaceutical companies or doctors
• Browse pharmaceutical payments by medical specialty
• Browse pharmaceutical payments by state